SMS-IC’s focus is on linking Scotland’s domain expertise, data assets and delivery capability to accelerate the adoption of Precision Medicine ie new products and services for a global market. SMS-IC uses its platform technologies to collaborate with NHS Scotland, industry and academia to reduce the barriers to entry for precision medicine projects. It engages with NHS Scotland, academia, the SME community and the global pharmaceutical industry to generate new data via sequencing that can be integrated with data from multiple sources such as imaging,digital pathology and clinical data from the electronic health record, to facilitate the development and validation of novel targets, enable new biomarkers discovery and companion diagnostics. The data should ultimately be able to be used to stratfiy patients for experimental studies or clinical trials. SMS-IC is uniquely placed to make the most of Scotland's strengths in precision medicine. This aptitude is due to our stable homogenous population of ~ 5.5M people, unique patient identifier (CHI number), unified health system and world leading health informatics.